Antihyperlipidemics - Fibrates: Nursing Pharmacology | Osmosis
Lipid-lowering medications: Fibrates | Osmosis
Figure 1 | Fenofibrate | SpringerLink
Pemafibrate, a New Selective PPARα Modulator: Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic Diseases | SpringerLink
Mechanism of Action of Fibrates on Lipid and Lipoprotein Metabolism | Circulation
Fenofibrate in cancer: mechanisms involved in... | F1000Research
Fibric Acid Derivatives (FIBRATES)
Structure and metabolic pathway for fenofibrate and fenofibric acid... | Download Scientific Diagram
Lowering lipid mechanisms of fenofibrate. Fenifibrate activates PPARα,... | Download Scientific Diagram
Fibrate pharmacogenomics: expanding past the genome | Pharmacogenomics
Clinical Applications of a Novel Selective PPARα Modulator, Pemafibrate, in Dyslipidemia and Metabolic Diseases. - Abstract - Europe PMC
Pharmaceuticals | Free Full-Text | Fenofibrate Nanocrystal Composite Microparticles for Intestine-Specific Oral Drug Delivery System | HTML
Fenofibrate improves vascular endothelial function and contractility in diabetic mice - ScienceDirect
Fenofibrate Increases Very Low Density Lipoprotein Triglyceride Production Despite Reducing Plasma Triglyceride Levels in APOE*3-Leiden.CETP Mice* - Journal of Biological Chemistry
Management of Hyperlipoprotinaemia - ppt video online download
Fenofibrate - Wikipedia
Fenofibrate | C20H21ClO4 - PubChem
Simplified PPARα dependent mechanism of action of fenofibrate on lipid... | Download Scientific Diagram
Potent and PPARα-independent anti-proliferative action of the hypolipidemic drug fenofibrate in VEGF-dependent angiosarcomas in vitro | Scientific Reports
Lipid Control Drugs | Concise Medical Knowledge
The Mechanism of Action of Ezetimibe (Zetia) on the Inhibition of Cholesterol Absorption
Proposed mechanism of fenofibrate action in the rescue of... | Download Scientific Diagram
